SCHEMBL6205271

SCHEMBL6205271

COC([O])c1ccc(C#N)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HTT P42858 1/20 0.42
GSK3B P49841 2/20 0.41
CYP19A1 P11511 6/20 0.40
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA2 P00918 3/20 0.38
CA9 Q16790 2/20 0.38
CA12 O43570 1/20 0.38
CA3 P07451 1/20 0.38
CA6 P23280 1/20 0.38
CA14 Q9ULX7 1/20 0.38
GRIA1 P42261 1/20 0.37
GRIA2 P42262 1/20 0.37
GRIA3 P42263 1/20 0.37
GRIA4 P48058 1/20 0.37
CA1 P00915 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7385564 0.78 CYP2A6 (0.46) CYP2A6ALDH1A1HTTCYP19A1KDM4E
SCHEMBL2266164 0.78 CYP2A6 (0.46) CYP2A6ALDH1A1HTTCYP19A1KDM4E
SCHEMBL6201138 0.77 GSK3B (0.44) GSK3B
SCHEMBL30187789 0.77 CYP19A1 (0.46) CYP2A6ALDH1A1HTTCYP19A1KDM4E
SCHEMBL6077332 0.75 CYP2A6 (0.43) CYP2A6ALDH1A1HTTCYP19A1CA2
SCHEMBL6205272 0.75 CYP2A6 (0.43) CYP2A6ALDH1A1HTTGSK3BCYP19A1
SCHEMBL27480613 0.73 CYP2A6 (0.41) CYP2A6ALDH1A1HTTCYP19A1KDM4E
SCHEMBL6202338 0.73 CYP1A2 (0.43) CYP2A6ALDH1A1KDM4EMAPT
SCHEMBL18965803 0.72 TSHR (0.48) CYP2A6ALDH1A1HTTCYP19A1TSHR
SCHEMBL11032485 0.72 KIF11 (0.46) CYP2A6ALDH1A1CYP19A1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed